In the past decade, extracellular vesicles (EVs) have been recognized as potent vehicles of
intercellular communication, both in prokaryotes and eukaryotes. This is due to their capacity …

Plasmodium vivax is geographically the most widely distributed cause of malaria in people,
with up to 2· 5 billion people at risk and an estimated 80 million to 300 million clinical cases …

Growing interest in extracellular vesicles (EVs, including exosomes and microvesicles) as
therapeutic entities, particularly in stem cell-related approaches, has underlined the need for …

The last decade has seen a sharp increase in the number of scientific publications
describing physiological and pathological functions of extracellular vesicles (EVs), a …

The malarial parasite Plasmodium vivax causes disease in humans, including chronic
infections and recurrent relapses, but the course of infection is rarely fatal,, unlike that …

The human malaria parasite Plasmodium vivax is responsible for 25–40% of the∼ 515
million annual cases of malaria worldwide. Although seldom fatal, the parasite elicits severe …

Merozoite surface antigen 1 (MSA1) of several species of plasmodia has been shown to be
a promising candidate for a vaccine directed against the asexual blood stages of malaria …

Abstract Background. Plasmodium falciparum and Plasmodium vivax are responsible for
most of the global burden of malaria. Although the accentuated pathogenicity of P …

The spleen is a complex organ that is perfectly adapted to selectively filtering and destroying
senescent red blood cells (RBCs), infectious microorganisms and Plasmodium‐parasitized …

Parasitic diseases affect billions of people and are considered a major public health issue.
Close to 400 species are estimated to parasitize humans, of which around 90 are …